Source link : https://www.newshealth.biz/health-news/game-changer-for-young-patients/
In just 4 years, there’s been a significant evolution in the profile of pediatric and young adult patients who’ve taken the chimeric antigen receptor (CAR) T-cell immunotherapy known as tisagenlecleucel (Kymriah) for relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL), a new industry-funded study finds. It’s becoming more common for patients with less severe disease to undergo […]
Author : News Health
Publish date : 2024-06-07 09:57:54
Copyright for syndicated content belongs to the linked Source.
Categories